Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year...

Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme

Carla E. M. Hollak, Derralynn Hughes, Ivo N. van Schaik, Barbara Schwierin, Bruno Bembi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Year:
2009
Language:
english
Pages:
8
DOI:
10.1002/pds.1779
File:
PDF, 96 KB
english, 2009
Conversion to is in progress
Conversion to is failed